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S U M M A R Y
Objectives: To evaluate the role of 18-ﬂuoro-2-deoxyglucose positron emission tomography–computed
tomography (18F-FDG-PET–CT) in the diagnosis of infectious endocarditis (IE).
Methods: We retrospectively examined 27 consecutive patients who were admitted to the Infectious
Diseases Department of Tor Vergata University Hospital between 2009 and 2013 with a suspicion of IE.
The ﬁnal IE diagnosis was deﬁned according to the modiﬁed Duke criteria, and the microbiological and
diagnostic results were collected for each patient.
Results: Twenty out of 27 patients had a suspected prosthetic valve endocarditis (PVE) and seven had a
suspected native valve endocarditis (NVE). Twenty-ﬁve out of 27 patients (92%) had a conﬁrmed
diagnosis of IE (18/25 PVE and 7/25 NVE); 16 had a positive echocardiography evaluation and 16 had
positive 18F-FDG-PET–CT ﬁndings. Echocardiography showed a higher sensitivity as a diagnostic tool for
the detection of IE compared to 18F-FDG-PET–CT (80% vs. 55%). However, a greater number of PVE had
positive 18F-FDG-PET–CT results compared to those with positive echocardiography ﬁndings (11/13 vs.
9/13), and overall 89% (16/18) of conﬁrmed PVE resulted 18F-FDG-PET–CT positive. Analyzing only the
cases who underwent transoesophageal echocardiography, 18F-FDG-PET–CT showed a sensitivity of 85%
in PVE (vs. 69% for echocardiography and 77% for the Duke criteria). All seven patients with NVE had a
positive echocardiography and negative 18F-FDG-PET–CT ﬁndings (p < 0.001).
Conclusions: The results of this study further highlight the limitations of echocardiography in the
diagnosis of PVE and the potential advantages of 18F-FDG-PET–CT in these cases.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Infective endocarditis (IE) continues to be an important medical
issue. The incidence of IE ranges from 3 to 10 episodes/100 000
person-years, and the risk of developing IE increases dramatically
with age (14.5 episodes/100 000 person-years for patients aged
70–80 years).1,2 Over the past 30 years, neither the incidence nor§ This study was presented in part at the 53rd Interscience Conference on
Antimicrobial Agents and Chemotherapy (ICAAC abstract M-240), Denver, Color-
ado, USA, September 10–13, 2013.
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).the associated mortality has decreased, despite major advances in
both diagnostic and therapeutic procedures. New predisposing
factors have been identiﬁed, such as valve prostheses, degenera-
tive valve sclerosis, and intravenous drug abuse.1
Prosthetic valve endocarditis (PVE) represents an extremely
serious medical condition with a potentially deleterious outcome.
PVE accounts for 10–30% of all cases of IE and occurs in 1–6% of
patients with valve prostheses, with an incidence of 0.3–1.2% per
patient/year.2 A deﬁnitive IE diagnosis is based on the revised Duke
criteria3 and is generally more difﬁcult for prosthetic than native
valves,4 as transthoracic echocardiography (TTE) has limited
diagnostic power on prosthetic valves. Transoesophageal echocar-
diography (TEE) is essential in patients suspected for PVE,ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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individual patient’s morphology, instrumental settings, transducer
position, operator, and artefacts from heavy valve calciﬁcations
and metallic prosthetic valves through acoustic shadowing.
Therefore, if an initial echocardiography is negative, repeated
TEE examinations are recommended in cases of clinical suspi-
cion.5,6 The question of whether performing TTE prior to TEE is
necessary in the evaluation of suspected prosthetic valve vegeta-
tions is a difﬁcult one. Guidelines provided by the American Heart
Association, American College of Cardiology, and American Society
of Echocardiography in 2003,7 stated that sequential examinations
starting with TTE is the preferred approach given the essential
information on cardiac function and haemodynamics provided by
TTE. However, particularly in the case of PVE, protocols in which
TTE is ordered ﬁrst may subject patients to unnecessary delays in
diagnosis as well as increased overall costs, and also the results of
this test are more frequently negative for PVE.8
18-Fluoro-2-deoxyglucose positron emission tomography–
computed tomography (18F-FDG-PET–CT) (ﬂuorodeoxyglucose
labelled with ﬂuorine-18) is a well-recognized imaging tool that
is most often used in oncology, but also in infectious diseases,
vasculitis, cardiology, and neurology disorders;9–12 increased
levels of glucose are detected in granulocytes and monocytes.
Emerging data suggest a role for 18F-FDG-PET–CT in the diagnosis
of endocarditis and endovascular graft and pacing system
infections when conventional diagnostic tools have failed.13–16
The aim of this study was to evaluate the diagnostic efﬁcacy of
18F-FDG-PET–CT in native valve endocarditis (NVE) and PVE in a
group of patients referred to our department with a suspicion of IE
during the period 2008–2013.
2. Methods
2.1. Patients
Between January 2008 and October 2013, 27 consecutive
patients were admitted to the Infectious Disease Department with
a suspicion of IE. On admission, the evaluation of possible and
deﬁnite IE cases was based on the clinical and/or pathological
modiﬁed Duke criteria.3 The ﬁnal IE diagnosis was deﬁned
according to the modiﬁed Duke criteria and the microbiological
and diagnostic results collected from each patient. The assessment
of individual cases on the basis of the above criteria allowed us to
conﬁrm or reject the diagnosis of IE.
All of the patients underwent physical examinations, laboratory
investigations, culture tests, and additional diagnostic procedures,
including chest X-ray, abdominal ultrasound, and TTE. As a result of
technical problems, intolerance, or patient refusal, TEE examination
was limited to only 11 patients. All of the accepted patients
underwent 18F-FDG-PET–CT at admission, a median of 4 days (range
3–8 days) after the start of antibiotic therapy. 18F-FDG-PET–CT wasFigure 1. Transverse images from an 83-year-old woman with PVE: (A) 18F-FDG-PET–CT; 
the aortic prosthesis.used as an additional tool to conﬁrm the diagnosis of IE, to evaluate
peri-valve extensions and early peripheral embolisms, or to rule out
other infectious foci, and was never used alone to assess the clinical
management of the patients.
Late PVE was deﬁned as an infection that presented at >12
months after heart surgery, and early PVE as an infection that
presented at <12 months after surgery.
Demographic, clinical, microbiological, and treatment data
were collected retrospectively. The ethics committee of Tor
Vergata University Hospital approved this study.
2.2. 18F-FDG-PET–CT
All patients underwent 18F-FDG-PET–CT in the resting state
after eating a meal rich in fat and low in carbohydrates to reduce
the physiological uptake of FDG in the myocardium.17 The test was
performed after a 6-h fasting period. Glycaemia was determined to
be 120 mg/dl at the time of the study. One hour after the
intravenous injection of 4 MBq/kg 18F-FDG, a low-dose whole-
body CT scan from the mid-thigh to the vertex was acquired using a
Discovery VCT PET/CT (GE Healthcare, Milwaukee, WI, USA). Once
the CT imaging was completed, PET acquisition was performed in
the three-dimensional mode, and the data were reconstructed
using the iterative method (algorithm OSEM); the CT data were
used for attenuation correction.
2.3. Interpretation of 18F-FDG-PET–CT
The cardiac images were interpreted independently by two
nuclear medicine physicians who were blinded to the clinical data
and other imaging studies. In two cases where the two physicians
disagreed on a diagnosis, consensus was reached via a third
physician. In patients with suspected NVE, any increase in FDG
uptake in or around the heart valves outside the myocardium was
considered abnormal. In patients with suspected PVE, the analysis
was performed on both the attenuation-corrected and non-
attenuation-corrected images, and the presence of hotspots in
the prosthetic and periprosthetic areas was considered abnormal
(Figures 1 and 2).
2.4. Statistical analysis
This should be considered a retrospective and observational
study. Continuous variables are expressed as the mean value.
Categorical data are expressed as numbers with percentages. The
sensitivity, speciﬁcity, positive predictive value (PPV), and nega-
tive predictive value (NPV) were calculated using the ﬁnal
diagnoses of conﬁrmed NVE or PVE and the rejected NVE or PVE
as the outcomes. The sensitivity, speciﬁcity, NPV, and PPV of the
Duke criteria, echocardiography (TTE and TEE), and 18F-FDG-PET–
CT were calculated based on the ﬁnal diagnosis of IE using SPSS(B) CT; (C) integrated 18F-FDG-PET–CT. High FDG uptake was observed at the level of
Figure 2. Transverse images from a 63-year-old man with NVE: (A) 18F-FDG-PET–CT; (B) CT; (C) integrated 18F-FDG-PET–CT. PET/CT detected no 18F-FDG accumulation in the
aortic valve vegetation, which was detected by TEE.
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sided. A p-value of <0.05 was considered signiﬁcant.
3. Results
Table 1 shows the characteristics of the 27 patients enrolled in
the study, 20 of whom had a prosthetic valve and seven of whom
had a native valve. The majority of the patients were men (74%, 20/
27), and the mean age was 63 years (range 41–83 years). At the
ﬁnal evaluation, the IE diagnosis was conﬁrmed in 25 of the 27
patients (92%), and these patients were treated with a standard
course of antibiotics in accordance with international guidelines.1,2
In two cases (patients 17 and 18) with a possible IE diagnosis
according to the modiﬁed Duke criteria at admission, the ﬁnal IE
diagnosis was rejected. Of the 25 patients with a conﬁrmed IE ﬁnal
diagnosis, 18 (72%) had PVE (16 aortic and two mitral prosthetic
valves). Eight patients (44.4%) had an early infection, with a mean
time to onset from surgery of 5 months, whereas 10 patients
(55.5%) had a late infection, with a mean time to onset from
surgery of 12 months. Seven (28%) out of 25 patients had NVE.
All 20 PVE patients underwent TTE at the initial diagnostic
evaluation and only nine patients were subsequently evaluated by
TEE. In ﬁve out of 11 patients (patients 10, 12, 14, 16, and 19) not
evaluated with TEE, the TTE resulted positive for IE; the remaining
six patients refused or did not tolerate the examination. Five of
these (patients 1, 3, 4, 7, and 20) were conﬁrmed with IE at the ﬁnal
evaluation and were treated successfully with antibiotics accord-
ing to the procedures and time limits established in international
guidelines. For the sixth patient (patient 18), the diagnosis of IE
was rejected.
Only two out of nine patients who underwent TEE (patients 9
and 15) the exam provide additional diagnostic information to TTE.
Seven out of the nine patients with positive TEE ﬁndings also had a
positive 18F-FDG-PET–CT result and had a conﬁrmed IE diagnosis at
the ﬁnal evaluation. The other two patients, one with a positive and
one with a negative TEE evaluation, had negative 18F-FDG-PET–CT
results. The last patient (patient 17) had a rejected IE ﬁnal
diagnosis. All patients with NVE had evidence of vegetations on
TTE; TEE was done in only two cases, which conﬁrmed TTE
ﬁndings.
Due to persistent infections despite antibiotic treatment, valve
replacements were needed in seven cases (four with PVE and three
with NVE), and a valvuloplasty was needed in one case. A
prolonged antibiotic course (6–12 months) was needed for 10 PVE
cases in whom prosthetic valve replacement was not possible due
to the high surgical risk. Valve infections were conﬁrmed by
biopsy’ in two cases (patient 6 Enterococcus faecalis, and patient 10
Candida parapsilosis).
There were four in-hospital deaths (14%) due to complications
of sepsis (Table 1; patients 1, 11, 16, and 24). The remaining 21
patients were treated successfully and were considered infection-
free when screened at the scheduled follow-up.
The main presenting symptoms of suspected IE were fever of
unknown origin (17/27, 62%), bacteraemia or sepsis (5/27, 18%),major vascular phenomena (3/27, 11%), vegetations (10/27, 37%),
valvular or perivalvular damage (3/27, 11%) as determined by TTE,
and dyspnoea and chest pain in one case.
In the 25 cases of conﬁrmed IE, the causative microorganisms
were coagulase-negative staphylococci in four cases, Enterococcus
faecalis in six cases, Streptococcus viridans in four cases, Candida
parapsilosis in two cases, methicillin-sensitive Staphylococcus
aureus (MSSA) in two cases, Pseudomonas aeruginosa in two cases,
methicillin-resistant S. aureus with reduced susceptibility to
vancomycin (hetero-VISA) in one case, Streptococcus bovis in one
case, and Enterococcus spp in one case (organism identiﬁed through
molecular testing). Four patients had culture-negative IE; these
patients were taking antibiotics at the time of clinical evaluation
and tested negative for Coxiella burnetii serology (data not shown).
Table 2 shows a comparison of the revised Duke criteria
evaluations, TTE or TEE echocardiogram ﬁndings, and 18F-FDG-
PET–CT scan results. The comparison of the different methods was
conducted on only 22 out of the 27 subjects studied, considering
only PVE patients with positive echocardiography evaluations and
ruling out patients without a TEE evaluation. In this table, the
sensitivity, speciﬁcity, PPV, and NPV for the overall studied
patients (section A) and separately for the 15 patients with
suspected PVE (section B) and the seven patients with NVE (section
C) were reported according to the ﬁnal diagnosis of conﬁrmed or
rejected IE.
In section A, according to the Duke criteria, only two patients
with possible IE were not conﬁrmed at the ﬁnal evaluation
(sensitivity 70%, speciﬁcity 100%, PPV 100%, and NPV 25%). At the
echocardiography (TTE or TEE) evaluation, 16 out of 20 patients
with conﬁrmed IE had positive ﬁndings (sensitivity 80%, speciﬁcity
100%, PPV 100%, and NPV 33%). Finally, 11 out of 20 patients with a
conﬁrmed IE ﬁnal diagnosis had positive 18F-FDG-PET–CT results
(sensitivity 55%, speciﬁcity 100%, PPV 100%, and NPV 18%). The
diagnostic tool with the greatest sensitivity in detecting IE in the
total studied population was echocardiography (80% vs. 70% for the
revised Duke criteria and vs. 55% for 18F-FDG-PET–CT).
In section B, 13 out of 15 patients with suspected PVE had a
conﬁrmed IE ﬁnal diagnosis. Four of these patients had negative
echocardiography results, and two of these patients had negative
18F-FDG-PET–CT results. 18F-FDG-PET–CT showed a sensitivity of
85% (vs. 69% for echocardiography and 77% for the revised Duke
criteria). A greater number of patients with PVE had positive 18F-
FDG-PET–CT results compared to those with positive echocardi-
ography ﬁndings (11/13 vs. 9/13).
In section C, all seven patients with NVE had positive
echocardiography and negative 18F-FDG-PET–CT ﬁndings
(p < 0.001). The echocardiography ﬁndings had a sensitivity of
100% (vs. 57% for the revised Duke criteria).
4. Discussion
In this retrospective study of patients with suspected IE,
echocardiography was shown to have the highest sensitivity (80%)
as a diagnostic tool in evaluating the overall population. The ability
Table 1
Characteristics of the study population
No. Sex, age Medical history Microbiological
blood culture
Valve Onset from
surgery
Increased uptake
of 18F-FDG-PET–CT
TTE TEE Duke criteria IE ﬁnal
diagnosis
1 M, 74 y Persistent fever Candida parapsilosis Aortic and mitral
prosthetic valve
7 y, late Prosthetic valve Negative Not done Possible; 1 major, 2 minor Conﬁrmed
2 M, 83 y Asthenia and fever Enterococcus faecalis Aortic prosthetic
valve
7 y, late Prosthetic valve Negative Negative Possible; 1 major, 1 minor Conﬁrmed
3 M, 77 y Fever Enterococcus faecalis Aortic prosthetic
valve
7 mo, early Prosthetic valve Negative Not done Possible; 1 major, 1 minor Conﬁrmed
4 M, 78 y Asthenia and fever Enterococcus faecalis Aortic prosthetic
valve
6 y, late Prosthetic valve Negative Not done Possible; 1 major, 2 minor Conﬁrmed
5 F, 61 y Fever and malaise Pseudomonas aeruginosa Aortic prosthetic
valve, Bentall
6 mo, early Prosthetic valve Negative Negative Possible; 1 major, 2 minor Conﬁrmed
6 M, 50 y Asthenia and fever Enterococcus faecalis Aortic prosthetic
valve
3 mo, early Prosthetic valve Negative Negative Possible; 1 major, 1 minor Conﬁrmed
7 F, 83 y Ischaemic occipital
stroke and fever
Streptococcus mutans Aortic prosthetic
valve
2 y, late Prosthetic valve Negative Not done Possible; 1 major, 2 minor Conﬁrmed
8 F, 74 y Ischaemic occipital
stroke and fever
Staphylococcus
haemolyticus
Aortic prosthetic
valve, Bentall
7 mo, early Prosthetic valve Negative Negative Deﬁnite; 1 major, 3 minor Conﬁrmed
9 M, 70 y Severe sepsis Staphylococcus
epidermidis
Aortic prosthetic
valve
3 mo, early Prosthetic valve Negative Abscess Deﬁnite; 2 major Conﬁrmed
10 F, 45 y Fever and hepatitis Candida parapsilosis Aortic prosthetic
valve
2 mo, early Perivalvular abscess Fistula Not done Deﬁnite; 2 major Conﬁrmed
11 M, 56 y Severe sepsis MSSA Aortic prosthetic
valve, Bentall
9 mo, early Prosthetic valve, Bentall Aortic vegetation Vegetation Deﬁnite; 2 major Conﬁrmed
12 M, 79 y Fever Streptococcus bovis Biological aortic
valve, Bentall
15 mo, late Prosthetic valve, Bentall Aortic vegetation Not done Deﬁnite; 2 major Conﬁrmed
13 F, 69 y Dyspnoea and
episodic fever
Streptococcus mitis Biological mitral
prosthesis
9 y, late Prosthetic valve Mitral vegetation Vegetation Deﬁnite; 2 major Conﬁrmed
14 F, 54 y Severe sepsis B/C negative Aortic prosthetic
valve, Bentall
28 y, late Prosthetic valve Leak prosthetic
valve; aortic
aneurysm
Not done Deﬁnite; 2 major Conﬁrmed
15 M, 60 y Bacteraemia,
CVC infection
hVISA Mitral prosthetic
valve
10 y, late Negative Negative Vegetation Deﬁnite; 2 major Conﬁrmed
16 M, 72 y Fever and lung cancer MSSA Aortic prosthetic
valve
12 y, late Negative Aortic vegetation Not done Deﬁnite; 2 major Conﬁrmed
17 M, 76 y Fever Staphylococcus hominis Aortic prosthetic
valve
3 y, late Negative Negative Negative Possible; 1 major, 2 minor Rejected
18 M, 42 y Fever B/C negative Aortic prosthetic
valve
16 mo, late Negative Negative Not done Possible; 5 minor Rejected
19 M, 62 Dyspnoea and
chest pain
Enterococcus faecalis Aortic prosthetic
valve, Bentall
13 mo, late Prosthetic valve Detachment of valve
pseudo-aneurysm
Not done Deﬁnite; 2 major Conﬁrmed
20 M, 43 Septic shock Pseudomonas aeruginosa Aortic prosthetic
valve, Bentall
10 mo, early Prosthetic valve Negative Not done Possible; 1 major, 2 minor Conﬁrmed
21 M, 50 y Fever Enterococcus faecalis Native aortic NA Negative Aortic vegetation Not done Deﬁnite; 2 major Conﬁrmed
22 M, 63 y Fever and pneumonia Staphylococcus
haemolyticus
Native aortic NA Negative Aortic vegetation Not done Deﬁnite; 2 major Conﬁrmed
23 M, 67 y Fever Streptococcus oralis Native mitral NA Negative Flail posterior leaﬂet Flail posterior
leaﬂet
Deﬁnite; 2 major Conﬁrmed
24 F, 59 y Ischaemic occipital
stroke and fever
B/C negative Native aortic/mitral NA Negative Aortic and mitral
vegetations
Not done Possible; 1 major, 2 minor Conﬁrmed
25 M, 41 y Aortic vegetation,
fever and malaise
B/C negative,
Enterococcus sppa
Native aortic NA Negative Aortic vegetation Vegetation Possible; 1 major, 1 minor Conﬁrmed
26 M, 51 y Fever (1 month) B/C negative Native aortic NA Negative Aortic vegetation Not done Possible; 1 major, 1 minor Conﬁrmed
27 M, 72 y Fever (1 month) Streptococcus
parasanguinis
Native aortic NA Negative Mitral vegetation Not done Deﬁnite; 2 major Conﬁrmed
TTE, transthoracic echocardiography; TEE, transoesophageal echocardiography; IE, infective endocarditis; M,male; F, female;mo,months; y, years; MSSA,methicillin-sensitive Staphylococcus aureus; B/C, blood culture; CVC, central
venous catheter; hVISA, heterogeneous vancomycin-intermediate Staphylococcus aureus.
a Organism identiﬁed through molecular testing.
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Table 2
Comparison of the revised Duke criteria evaluation, TTE or TEE echo ﬁndings, and 18F-FDG-PET–CT scan results of 22 out of the 27 patients with suspected IE
IE conﬁrmed IE not
conﬁrmed
A. Results of the total population of 22
patients
(n = 20) (n = 2)
Duke criteria Deﬁnite 14 0 Sensitivity 70%; speciﬁcity 100%; PPV 100%; NPV 25%
Possible 6 2
Echocardiographya Positive 16 0 Sensitivity 80%; speciﬁcity 100%; PPV 100%; NPV 33%
Negative 4 2
18F-FDG-PET–CT Positive 11 0 Sensitivity 55%; speciﬁcity 100%; PPV 100%; NPV 18%
Negative 9 2
B. Results of 15 patients with suspected PVE (n = 13) (n = 2)
Duke criteria Deﬁnite 10 0 Sensitivity 77%; speciﬁcity 100%; PPV 100%; NPV 40%
Possible 3 2
Echocardiographya Positive 9 0 Sensitivity 69%; speciﬁcity 100%; PPV 100%; NPV 33%
Negative 4 2
18F-FDG-PET–CT Positive 11 0 Sensitivity 85%; speciﬁcity 100%; PPV 100%; NPV 50%
Negative 2 2
C. Results of 7 patients with suspected NVE (n = 7) (n = 0)
Duke criteria Deﬁnite 4 0 Sensitivity 57%; speciﬁcity NE; PPV 100%; NPV NE
Possible 3 0
Echocardiographya Positive 7 0 Sensitivity 100%; speciﬁcity NE; PPV 100%; NPV NE
Negative 0 0
18F-FDG-PET–CT Positive 0 0 Sensitivity NE; speciﬁcity NE; PPV NE; NPV NE
Negative 7 0
IE, infective endocarditis; TTE, transthoracic echocardiography; TEE, transoesophageal echocardiography; 18F-FDG-PET–CT, combined ﬂuorodeoxyglucose labelled with
ﬂuorine-18 positron emission tomography and computed tomography; PPV, positive predictive value; NPV, negative predictive value; PVE, prosthetic valve endocarditis;
NVE, native valve endocarditis; NE, not evaluable.
a Positive: patients with a positive TEE or TTE; negative: patients with a negative TEE and TTE.
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used (18–33%), and 18F-FDG-PET–CT did not provide any
additional diagnostic value to the revised Duke criteria. However,
when patients with PVE and NVE were analysed separately, several
interesting results emerged. 18F-FDG-PET–CT was the most
effective tool at diagnosing PVE, with a sensitivity of 85% and an
NPV of 50% when evaluated against the results obtained by
echocardiography. In addition, 89% overall of conﬁrmed PVE had a
positive 18F-FDG-PET–CT result. The revised Duke criteria and
echocardiography ﬁndings showed good, although reduced
compared to 18F-FDG-PET–CT, sensitivity for PVE (77% and 69%,
respectively), but a poor ability to rule out the diagnosis (NPV 28%
and 25%, respectively). The situation was completely reversed in
patients with NVE: 18F-FDG-PET–CT failed to detect the infection in
all cases, demonstrating that this tool is not appropriate for
establishing or ruling out infection of native cardiac valves.
Recent guidelines have highlighted how echocardiography
ﬁndings and microbiology results can be inconclusive in patients
with cardiac devices or valvular prostheses.2,3 This is often related
to the elusive clinical presentation and the challenging interpreta-
tion of the echocardiography ﬁndings (thickened valves, nodules,
or valvular calciﬁcations) in the presence of prosthetic devices.
Recent studies have investigated the role of 18F-FDG-PET–CT in
detecting infectious foci in critically ill patients and in detecting IE
complications, and some clinical reports have suggested the
feasibility and potential value of the 18F-FDG-PET–CT scan in
diagnosing IE.18,19 A number of individual case reports and a small
clinical series have reported conﬂicting results regarding the use of
18F-FDG-PET–CT as an additional diagnostic tool in situations
where other tests have failed to provide a deﬁnitive diagnosis. Yen
et al.20 demonstrated that 18F-FDG-PET–CT could diagnose IE that
was conﬁrmed by positive blood cultures in a study of six patients,
and Mogadam-Kia et al.21 demonstrated increased 18F-FDG-PET–
CT uptake in the prosthetic valve that was consistent with IE in a
patient with prolonged fever and an absence of clear vegetations.
Conversely, Kouijzer et al. recently reported an 18F-FDG-PET–CT
sensitivity of 39% (speciﬁcity 93%) in a population of 18 patients
with IE,22 demonstrating the low diagnostic power of this tool. Inthis study, only two patients had PVE, and one of these patients had
positive 18F-FDG-PET–CT ﬁndings. In a recent paper by Saby et al.
regarding PVE, 18F-FDG-PET–CT demonstrated a PPV of 85%, and
the authors proposed the addition of abnormal FDG uptake around
the prosthetic valve as a new major criterion of the modiﬁed Duke
criteria.23 Millar and colleagues24 recently reviewed more than 30
published papers on the potential role of 18F-FDG-PET–CT in the
diagnosis of IE. The authors highlighted the limitations of
echocardiography in the presence of a cardiac prosthetic valve
infection and the potential advantages of 18F-FDG-PET–CT, of
which the reported overall sensitivity on PVE was 83.3% vs. 27.2%
for echocardiography. Similar results were reported by Sarrazin
and co-workers regarding cardiovascular implantable electronic
device infections, in which 18F-FDG-PET–CT was positive in 76%
(32/42) of the infected device cases compared to the lack of uptake
in six control patients.25 In a more recent paper, Erba et al.
summarized the published evidence regarding the usefulness of
18F-FDG-PET–CT in the diagnosis of IE. The authors support the use
of 18F-FDG-PET–CT, in association with echocardiography, to
conﬁrm or rule out IE in equivocal or difﬁcult to explore situations,
such as those due to artefacts caused by mechanical prostheses or
device catheters.26
As with other imaging options, 18F-FDG-PET–CT does not
identify infection per se. Rather it identiﬁes the metabolically
active cells, such as leukocytes, that are responding to inﬂamma-
tion or infection. Similarly, suppression of infection by a prolonged
course of antibiotics prior to 18F-FDG-PET–CT scanning may result
in false-negative images. Moreover, some authors have suggested
that limited uptake of the 18F-FDG tracer can be due to small
vegetation sizes below the detection threshold of the tracer.27
Additionally, hyperglycaemia may interfere with this process and
can lead to false-negative results. In our study, these reasons do not
explain the negative 18F-FDG-PET–CT scans in patients with NVE.
More likely, as some authors have suggested, the 18F-FDG-PET–CT
scans do not show vegetations that are normally seen by TTE/TEE;
rather, 18F-FDG-PET–CT shows valvular and perivalvular infections
indicative of infectious processes or small abscesses at the valvular
position, which are more easily detectable in the case of prosthetic
A. Ricciardi et al. / International Journal of Infectious Diseases 28 (2014) 219–224224infections.18 False-positive scans may also occur in patients with
recently implanted vascular devices.19 In our study, eight patients
had early PVE, which occurred less than 12 months after surgery
(mean 5 months, range 3–9 months). All of these patients had
conﬁrmed IE on the basis of positive blood cultures for a typical
microorganism and positive 18F-FDG-PET–CT results at the site of
engraftment, without any other possible sources of infection.
Several studies have evaluated the role of 18F-FDG-PET–CT in
the diagnosis of focal infections or inﬂammatory diseases in
critically and non-critically ill patients, and have found a NPV of
nearly 100%, thus concluding that negative 18F-FDG-PET–CT scans
almost certainly appear to exclude focal infections as a cause of
clinical symptoms.12 Moreover, a recent extensive study described
the excellent sensitivity and anatomical precision of 18F-FDG-PET–
CT for the early detection of embolisms and metastatic infections
secondary to IE.18 In our study population, 18F-FDG-PET–CT also
demonstrated peripheral embolism (cerebral, splenic, and intesti-
nal) in six cases (ﬁve PVE and one NVE) (data not shown).
Before drawing conclusions, some limitations of our study must
be discussed. First, the small number of patients studied does not
provide sufﬁcient strength for the routine use of 18F-FDG-PET–CT
for PVE diagnosis. Second, we evaluated cases of IE admitted
consecutively to our infectious diseases ward, coming from other
wards of the hospital in which the suspected diagnosis was based
on the modiﬁed Duke criteria. This could be considered a bias of
our study, as we enrolled consecutive patients with a strong
suspicion of IE and this explains the very low number of patients
for whom the IE diagnosis was rejected.
Otherwise, taking into account the limitations mentioned
above, the results of the present study suggest the potential
advantage of 18F-FDG-PET–CT in the diagnosis of IE in patients with
prosthetic cardiac valves, particularly in cases in whom negative
echocardiography ﬁndings or negative blood cultures make a
deﬁned IE diagnosis difﬁcult.
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